MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education, and prevention. MD Anderson has ranked among the nation's top ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades.

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Opens in a new tab or window Follicular lymphoma -- typically a slow ... of the University of Texas MD Anderson Cancer Center in Houston. However, he added, the evidence supporting that criteria ...

“That’s quite an accomplishment,” says Allison, professor and chair of immunology at The University of Texas MD Anderson Cancer Center. Ipilimumab received FDA approval for use in late-stage ...

Houston-based University of Texas MD Anderson Cancer Center broke ground on a new facility in Sugar Land, Texas, set to be the system’s largest location yet. Services at the new facility will ...

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have extended and expanded a collaboration exploring medicines targeting lung cancer with KRAS mutations. The ...

Enrollment is ongoing at multiple sites, including The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. The first patient has been enrolled in the phase 3 ...

For more information, click here. From MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer ...